Sfoglia per AUTORE
FALCONE A
Collezione AO Ordine Mauriziano

  

Items : 7

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31
2022
AO Ordine Mauriziano

Marconcini R; Intagliata S; Audisio M; Lai E; Aprile G; Buti S; Ghidini M; Macrini S; Inno A; Di Marino P; Tuzi A; Nicolardi L; Occhipinti MA; Pergolesi F; Veltri E; Adamo V; Filetti M; Ficorella C; Pantano F; Citarella F; Falcone A; Bossi P; Di Maio M; Scartozzi M; Di Noia V; Calvetti L; Bersanelli M; Grossi F; Gori S; et alii...

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Aug 20:JCO2001225. doi: 10.1200/JCO.20.01225.
2020
AO Ordine Mauriziano

Cremolini C; Antoniotti C; Stein A; Bendell J; Gruenberger T; Rossini D; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll HJ; Di Maio M;

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Boccadoro M; Vacca A; Dammacco F; Petrucci MT; Musto P; Montefusco V; Rizzo M; Falcone AP; Grasso M; Gottardi D; Leonardi G; Baldini L; Benevolo G; Callea V; Patriarca F; Guglielmelli T; Nozzoli C; Larocca A; Offidani M; De Paoli L; Martino E; Bringhen S; Palumbo A; Omedè P; Giuliani N; Saltarella I; Terragna C; Morabito F; et alii...

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. in Clinical colorectal cancer / Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.
2019
ASL Biella
ASL VCO
AO Ordine Mauriziano
AOU Città della Salute di Torino

Lièvre A; Montagnani F; Vasile E; Brac C; Aglietta M; Clerico M; Passardi A; Buscaglia P; Meurisse A; Pasquini G; Neuzillet C; Falcone A; Spadi R; Edeline J; Sperti E; Musettini G; Satolli MA; Vernerey D; De Luca E; Vivaldi C; Lombardi P; Vienot A; Casadei-Gardini A; Leone F; Fornaro L;

Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis. in Cancer research and treatment / Cancer Res Treat. 2017 Jul;49(3):834-845. doi: 10.4143/crt.2016.249. Epub 2016 Nov 15.
2017
AO Ordine Mauriziano

Loupakis F; Braud F; Bartolomeo MD; Sonetto C; Bironzo P; Nichetti F; Borelli B; Marmorino F; Salvatore L; Baratelli C; Tampellini M; Berenato R; Pietrantonio F; Antoniotti C; Cremolini C; Falcone A; Di Maio M;

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Fontanini G; Di Maio M; Milione M; Volpi C; Fucà G; Sensi E; Tamburini E; Tampellini M; Baratelli C; Zucchelli G; Busico A; Gloghini A; Rossini D; Perrone F; Tamborini E; Berenato R; Morano F; Moretto R; Cremolini C; De Braud F; Falcone A; Pietrantonio F;

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Mar 1;32(7):634-40. doi: 10.1200/JCO.2013.52.0023. Epub 2014 Jan 21.
2014
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Offidani M; Gaidano G; Passera R; Nozzoli C; Guglielmelli T; Mina R; Morabito F; Marasca R; Omedé P; Bringhen S; Larocca A; Rossi D; Di Raimondo F; Magarotto V; Patriarca F; Levi A; Benevolo G; Vincelli ID; Grasso M; Franceschini L; Gottardi D; Zambello R; Montefusco V; Falcone AP; Palumbo A; Petrucci MT; Musto P; Boccadoro M; et alii...